Key result
Contrary to historical beliefs, percutaneous closure is now a viable option for up to 75% of superior sinus venosus atrial septal defects, facilitated by transesophageal echocardiography.
Population
Adults with sinus venosus atrial septal defect (SVASD)
Design
Editorial
Authors
Loading...
Highlights that percutaneous closure is now a viable option for many patients with superior sinus venosus atrial septal defects, correcting a previous statement that they were not amenable to such treatment.
Highlights that percutaneous closure is now a viable option for many patients with superior sinus venosus atrial septal defects, correcting a previous statement that they were not amenable to such treatment.
Rosenthal et al. (2022) conducted a letter in Sinus venosus atrial septal defect. Percutaneous closure was evaluated. Contrary to historical beliefs, percutaneous closure is now a viable option for up to 75% of superior sinus venosus atrial septal defects, facilitated by transesophageal echocardiography.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: